BU-NOT-SET

CONTACT US
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
  • Drug substance
Man at poster
Poster
Recipharm Analytical Solutions™
  • Analytical chemistry
Icon
Fact sheet
Impurity identification
  • Analytical chemistry
Woman inserting vials in machine
Fact sheet
Stability studies
  • Analytical chemistry
hand holding vials plate
Fact sheet
Extractables & leachables testing
  • Analytical chemistry
Product mix
Fact sheet
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
  • Industry trends
Eyes
Insight
Global expansion in the CDMO field
  • Industry trends
Eyes
Insight
Fixed dose combinations - for improved patient compliance
  • Drug product
mini-tablets
Fact sheet
The current state of contract manufacturing
  • Industry trends
Eyes
Insight
White paper
  • Biologics
  • Manufacturing
Advanced Bio is advancing rAAV production
White paper
  • Biologics
  • Manufacturing
Advanced Bio Is advancing LNP formulation
White paper
  • Drug product
  • Manufacturing
Optimising drug formulation: The critical role of granulation
Case study
  • Drug product
  • Manufacturing
Overcoming fixed-dose combination challenges for ALS
Video
  • Industry trends
What’s shaping the future of pharma?
Insight
  • Drug product
  • Manufacturing
Mastering tech-transfer: Turning complexity into competitive advantage
Insight
  • Drug product
  • Manufacturing
Four ways ReciPredict can transform your pharma manufacturing
Insight
  • Analytical chemistry
  • Industry trends
An expert’s guide to analytical services
Insight
  • Drug product
  • Manufacturing
How lyophilisation can help overcome mRNA stability challenges